Innoviva, Inc. (INVA) Social Stream



Innoviva, Inc. (INVA): $15.54

0.24 (-1.52%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

B

Add INVA to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#17 of 357

in industry

INNOVIVA INC (INVA) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering INVA.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-12 1 $10 $10 $10 $16.41 -39.06%
2022-02-24 1 $12 $12 $12 $16.41 -26.87%
2022-05-09 1 $13 $13 $13 $16.41 -20.78%
2022-07-20 2 $16 $12 $14 $16.41 -14.69%
2022-08-08 2 $16 $13 $14.5 $16.41 -11.64%
2022-10-12 2 $16 $14 $15 $16.41 -8.59%
2022-11-14 2 $16 $14 $15 $16.41 -8.59%
2023-01-24 2 $16 $13 $14.5 $16.41 -11.64%
2023-03-03 3 $22.5 $10 $16.166 $16.41 -1.49%
2023-04-20 3 $22.5 $10 $15.166 $16.41 -7.58%
2023-09-30 2 $22.5 $14 $18.25 $16.41 11.21%

The Trend in the Analyst Price Target


INVA's average price target has moved up $8.25 over the prior 32 months.

Over the past 36 weeks, INVA's average upside potential has been 33.12%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-03 3 22.500 10 16.166 10.99 47.1%
2023-04-20 2 22.500 13 17.750 11.84 49.92%
2023-09-30 2 22.501 14 18.250 12.99 40.49%
2023-09-30 1 22.501 14 18.250 12.99 40.49%
2023-09-30 2 22.500 14 18.250 12.99 40.49%

INVA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2 1 0 1 0 0 2

The Trend in the Broker Recommendations


INVA's average broker recommendation rating improved by 1 over the prior 48 weeks.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for INVA as an investment opportunity.

  • In terms of how INNOVIVA INC fares relative to all US stocks, note that its number of analysts covering the stock is greater than 38.97% of that group.
  • INNOVIVA INC's upside potential (average analyst target price relative to current price) is greater than 158.55% of Pharmaceutical Products stocks.
  • INVA has a lower variance in analysts' estimates than -189.67% of Pharmaceutical Products stocks.
  • To contextualize these metrics, consider that out of stocks in the mid market cap category, INNOVIVA INC's average analyst price target is greater than 276.05% of them.

In the Pharmaceutical Products industry, ACAD, PTCT, and SAVA are the three stocks most similar to INNOVIVA INC regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding INVA using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!